Advanced search
Publication Cover
Expert Review of Dermatology Volume 7, 2012 - Issue 6
Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Worldwide elimination of leprosy: historical journey from the past to the future

PSS Sundar Rao The Leprosy Mission Trust India, New Delhi, India. [email protected]
Pages 513-520 | Published online: 10 Jan 2014

References

  • Browne SG. The history of leprosy. In: Leprosy (1st Edition). Hastings RC (Ed.). Churchill Livingstone, NY, USA, 1–14 (1985).
  • Trautman JR. A brief history of Hansen’s disease. The Star 50, 3–16 (1990).
  • Yawalkar SJ. Leprosy for Medical Practitioners and Paramedical Workers. CIBA-GEIGY limited, Basel, Switzerland (1994).
  • Rao PS, Raju MS, Barkataki A, Nanda NK, Kumar S. Extent and correlates of leprosy stigma in rural India. Indian J. Lepr. 80(2), 167–174 (2008).
  • Bullock W. Leprosy (Hansen’s disease). In: Cecil Textbook of Medicine (18th Edition). Wyngaarden JB, Smith LH (Eds). WB Saunders, PA, USA, 1696–1701 (1988).
  • WHO. Expert Committee on Leprosy, Seventh Report, Geneva. Technical Report Series, No. 874. WHO, Geneva, Switzerland (1998).
  • Stearns AT. Leprosy: a problem solved by 2000? Lepr. Rev. 73(3), 215–224 (2002).
  • WHO. Progress towards leprosy elimination. Wkly Epidemiol. Recun. 72, 165–172 (1997).
  • WHO. Weekly epidemiological record. Leprosy Update. No 36, 86, 389–400 (2011).
  • WHO. Chemotherapy of leprosy: report of a WHO study group. Technical Report Series, No. 847. WHO, Geneva, Switzerland (1994).
  • Britton WJ, Lockwood DN. Leprosy. Lancet 363(9416), 1209–1219 (2004).
  • Lockwood DN, Suneetha S. Leprosy: too complex a disease for a simple elimination paradigm. Bull. World Health Organ. 83(3), 230–235 (2005).
  • Bechelli LM. Prospects of global elimination of leprosy as a public health problem by the year 2000. Int. J. Lepr. Other Mycobact. Dis. 62(2), 284–292 (1994).
  • Jacobson RR, Krahenbuhl JL. Leprosy. Lancet 353(9153), 655–660 (1999).
  • Meyers WM. Leprosy research and patient care over the past century. Int. J. Lepr. Other Mycobact. Dis. 66(1), 43–48 (1998).
  • International Leprosy Association. Report of the International Leprosy Association Technical Forum; Lepr Rev. 25–28 Paris, France, 93 (2002).
  • Bennett BH, Parker DL, Robson M. Leprosy: steps along the journey of eradication. Public Health Rep. 123(2), 198–205 (2008).
  • WHO. World Health Assembly, Elimination of leprosy: resolution of the 44th World Health Assembly. Geneva: World Health Organization; Resolution No. WHA 44 (1991).
  • Gokhale SD. Multi-drug therapy is not enough. Round table: Eliminating leprosy as a public health problem – is the optimism justified? World Health Forum 17, 126–128 (1996).
  • Nsagha DS, Bamgboye EA, Assob JC et al. Elimination of leprosy as a public health problem by 2000 ad:an epidemiological perspective. Pan. Afr. Med. 9, 4 (2011).
  • Goulart IM, Goulart LR. Leprosy: diagnostic and control challenges for a worldwide disease. Arch. Dermatol. Res. 300(6), 269–290 (2008).
  • Brown W. Can social marketing approaches change community attitudes towards leprosy? Lepr. Rev. 77(2), 89–98 (2006).
  • Beyene D, Aseffa A, Harboe M et al. Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia. Epidemiol. Infect. 131(2), 841–848 (2003).
  • Sundar Rao PSS. Editorial current epidemiology of leprosy. India Lepr. Rev. 77, 292–294 (2006).
  • Lockwood DN. Commentary: leprosy and poverty. Int. J. Epidemiol. 33(2), 269–270 (2004).
  • Dhillon GPS, Barkakaty BN. National leprosy eradication programme in India: achievements and deficiencies. Health Admin. XVIII, 4–7 (2006).
  • Joshi PL. National scenario, National Leprosy Eradication Programme and new paradigms. In: IAL Text Book of Leprosy. Jaypee Brothers Medical Publishers, New Delhi, 35–43 (2010).
  • Narain JP, Dash AP, Parnell B et al. Elimination of neglected tropical diseases in the South-East Asia Region of the World Health Organization. Bull. World Health Organ. 88(3), 206–210 (2010).
  • Fine PE. Global leprosy statistics: a cause for pride, or frustration? Lepr. Rev. 77(4), 295–297 (2006).
  • Rao CK. There is still a long way to go. Round table Eliminating leprosy as a public health problem – is the optimism justified? World Health Forum 17, 137–139 (1996).
  • Porter JD. Supporting ‘the individual’ with leprosy: the need for a ‘post-elimination strategy’. Lepr. Rev. 75(1), 2–6 (2004).
  • Richardus JH, Habbema JD. The impact of leprosy control on the transmission of M. leprae: is elimination being attained? Lepr. Rev. 78(4), 330–337 (2007).
  • Durrheim DN, Fourie A, Balt E et al. Leprosy in Mpumalanga Province, South Africa – eliminated or hidden? Lepr. Rev. 73(4), 326–333 (2002).
  • Gidado M, Obasanya JO, Sani M et al. Leprosy elimination: successes story face with obvious challenges in Nigeria Kaduna State TB & Leprosy as a case study. Nig. J. Med., 1–10 (2008).
  • Jakeman P, Jakeman NR, Singay J. Trends in leprosy in the Kingdom of Bhutan, 1982–1992. Lepr. Rev. 66(1), 69–75 (1995).
  • Noordeen SK, Roxas MG, Fine PE et al. Eliminating leprosy as a public health problem – is the optimism justified? World Health Forum 17(2), 109–144 (1996).
  • Shetty VP. Challenges facing the control of leprosy in the Indian context. Ann. Acad. Med. Singap. 39(1), 1–3 (2010).
  • WHO. WHO’s Western Pacific Regional Office today urged its Member States to make a final push to address leprosy in the Region. WHO, Manila, Philippines (2012).
  • Sehgal VN, Sardana K, Dogra S. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status. J. Dermatolog. Treat. 19(2), 82–91 (2008).
  • WHO. Global leprosy situation 2004. WHO, Geneva, Switzerland (2005).
  • WHO. Leprosy Elimination Campaigns: impact on case detection. Wkly Epidemiol. Rec. 78, 9–16 (2003).
  • Penna ML, Penna GO. Trend of case detection and leprosy elimination in Brazil. Trop. Med. Int. Health 12(5), 647–650 (2007).
  • Kerr-Pontes LR, Montenegro AC, Barreto ML, Werneck GL, Feldmeier H. Inequality and leprosy in Northeast Brazil: an ecological study. Int. J. Epidemiol. 33(2), 262–269 (2004).
  • Al-Mutairi N, Al-Doukhi A, Ahmad MS, El-Khelwany M, Al-Haddad A. Changing demography of leprosy: Kuwait needs to be vigilant. Int. J. Infect. Dis. 14(10), e876–e880 (2010).
  • Frémont G, Bourrat E, Mahé E, Flageul B. [Leprosy in children: a diagnosis that must not be missed]. Ann. Dermatol. Venereol. 137(5), 359–363 (2010).
  • Pandey A, Rathod H. Integration of leprosy into GHS in India: a follow up study (2006–2007). Lepr. Rev. 81(4), 306–317 (2010).
  • Joshi PL, Thorat DM, Manglani PR. Need and strategy for sentinel surveillance for drug resistance in leprosy in India. Indian J. Lepr. 81(3), 113–118 (2009).
  • Siddiqui MR, Velidi NR, Pati S et al. Integration of leprosy elimination into primary health care in orissa, India. PLoS ONE 4(12), e8351 (2009).
  • Singh A. Internal evaluation of national leprosy elimination program in tribal Gujarat. Indian J. Community Med. 35(1), 130–133 (2010).
  • Kumar AS, Kumar S, Abraham S, Rao PS. Leprosy among tribal population of Chhattisgarh state, India. Indian J. Lepr. 83(1), 23–29 (2011).
  • Mendiratta V, Jain A, Chander R, Khan A, Barara M. A nine-year clinico-epidemiological study of Histoid Hansen in India. J. Infect. Dev. Ctries. 5(2), 128–131 (2011).
  • Kumar A, Chakma JK, Yadav VS, Girdhar A, Girdhar BK. Leprosy scenario in Agra: epidemiological observations from rapid population survey 2004–06. J. Commun. Dis. 40(4), 277–284 (2008).
  • Jopling WH, McDougall AC. Handbook of Leprosy (4th Edition). British Library Cataloguing in Publication Data William Heinemann Medical Books Ltd., London, UK. 616.9.98.ISBN 0-433-217569-9 (1988).
  • Mehndiratta RC, Patnaik A, John O, Rao PS. Does nerve examination improve diagnostic efficacy of the WHO classification of leprosy? Indian J. Dermatol. Venereol. Leprol. 74(4), 327–330 (2008).
  • Desikan KV. Elimination of leprosy & possibility of eradication – the Indian scenario. Indian J. Med. Res. 135, 3–5 (2012).
  • WHO. Progress towards leprosy elimination. Wkly Epidemiol Rec. 73, 153–160 (1998).
  • Visschedijk J, Engelhard A, Lever P, Grossi MA, Feenstra P. Leprosy control strategies and the integration of health services: an international perspective. Cad. Saude. Publica. 19(6), 1567–1581 (2003).
  • WHO. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (plan period: 2006–2010). (2005).
  • Pannikar V. Enhanced global strategy for further reducing the disease burden due to leprosy: 2011–2015. Lepr. Rev. 80(4), 353–354 (2009).
  • Nsagha DS, Bissek ACZK, Nsagha SM et al. Social stigma as an epidemiological determinant for leprosy elimination in Cameroon. J. Public Health Afri. 2, 38–44 (2011).
  • Nsagha DS, Bamgboye EA, Oyediran AB. Operational barriers to the implementation of multidrug therapy and leprosy elimination in Cameroon. Indian J. Dermatol. Venereol. Leprol. 75(5), 469–475 (2009).
  • Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin. Microbiol. Rev. 19(2), 338–381 (2006).
  • International Leprosy Congress. Future research needs in leprosy: highlights of the Pre Congress Workshop No.7. Lepr. Rev. 79, 223–229 (2008).
  • Smith C, Richardus JH. Leprosy strategy is about control, not eradication. Lancet 371(9617), 969–970 (2008).
  • Bobosha K, Van Der Ploeg-Van Schip JJ, Zewdie M et al. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa. Lepr. Rev. 82(4), 445–458 (2011).
  • Lahiri R, Randhawa B, Franken KL et al. Development of a mouse food pad model for detection of sub clinical leprosy. Lepr. Rev. 82(4), 432–444 (2011).
  • Spencer JS, Dockrell HM, Kim HJ et al. Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy. J. Immunol. 175(12), 7930–7938 (2005).
  • Geluk A, Klein MR, Franken KL et al. Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection. Infect. Immun. 73(9), 5636–5644 (2005).
  • Curtiss R 3rd, Blower S, Cooper K, Russell D, Silverstein S, Young L. Leprosy research in the post-genome era. Lepr. Rev. 72(1), 8–22 (2001).
  • Skinsnes OK. Immuno-epidemiology of leprosy. Int. J. Lepr. Other Mycobact. Dis. 43(2), 145–148 (1975).
  • Meima A, Gupte MD, van Oortmarssen GJ, Habbema JD. SIMLEP: a simulation model for leprosy transmission and control. Int. J. Lepr. Other Mycobact. Dis. 67(3), 215–236 (1999).
  • Fischer EA, de Vlas SJ, Habbema JD, Richardus JH. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl. Trop. Dis. 5(9), e1330 (2011).
  • Meima A, Smith WC, van Oortmarssen GJ, Richardus JH, Habbema JD. The future incidence of leprosy: a scenario analysis. Bull. World Health Organ. 82(5), 373–380 (2004).
  • Smith WC. What is the best way to use BCG to protect against leprosy: when, for whom, and how often? Int. J. Lepr. Other Mycobact. Dis. 72(1), 48–49 (2004).
  • Velema JP, Ogbeiwi OI. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy. Lepr. Rev. 78(2), 88–101 (2007).
  • Bakker MI, Hatta M, Kwenang A et al. Prevention of leprosy using rifampicin as chemoprophylaxis. Am. J. Trop. Med. Hyg. 72(4), 443–448 (2005).
  • Moet FJ, Oskam L, Faber R, Pahan D, Richardus JH. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Lepr. Rev. 75(4), 376–388 (2004).
  • Geluk A, Spencer JS, Bobosha K et al.; IDEAL Consortium. From genome-based in silico predictions to ex vivo verification of leprosy diagnosis. Clin. Vaccine Immunol. 16(3), 352–359 (2009).
  • Raju MS, Rao PS, Mutatkar RK. A study on community-based approaches to reduce leprosy stigma in India. Indian J. Lepr. 80(3), 267–273 (2008).
  • John AS, Rao PS, Das S. Assessment of needs and quality care issues of women with leprosy. Lepr. Rev. 81(1), 34–40 (2010).
  • Aráoz R, Honoré N, Banu S et al. Towards an immunodiagnostic test for leprosy. Microbes Infect. 8(8), 2270–2276 (2006).
  • Kuruwa S, Vissa V, Mistry N. A study of the distribution of Mycobacterium leprae Strains Among Cases in a Rural and Urban population of Maharashtra India. J. Clin. Microbiol. 50, 1406–1411 (2012).
  • Meima A, Irgens LM, van Oortmarssen GJ, Richardus JH, Habbema JD. Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach. Int. J. Epidemiol. 31(5), 991–1000 (2002).
  • Yoshie Y. Results of the leprosy programme in Japan in the past 60 years. Lepr. Rev. 41(1), 9–13 (1970).
  • Shen JP, Gupte MD, Jiang C, Manickam P, Yu MW, Li WZ. Trends of case detection and other indicators of leprosy in China during 1985–2002. Chin. Med. Sci. J. 20, 77–82 (2005).
  • Jacobson RR, Gatt P. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project. Lepr. Rev. 79(4), 410–415 (2008).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.